SCHEMBL31674009

SCHEMBL31674009

O=Cc1ccc2c(Cc3ccc(F)cc3F)nccc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ POLB P06746 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ PDE10A Q9Y233 1/20 0.39
▸ MPO P05164 1/20 0.35
▸ TRPA1 O75762 3/20 0.34
▸ GSK3B P49841 2/20 0.34
▸ BACE1 P56817 2/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ KDM4C Q9H3R0 1/20 0.34
▸ GAA P10253 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ TDP1 Q9NUW8 1/20 0.33
▸ PTGS2 P35354 2/20 0.33
▸ PTGS1 P23219 1/20 0.33
▸ IDO1 P14902 1/20 0.32
▸ TDO2 P48775 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12373439 0.79 TRPA1 (0.51) PDE10AMPOTRPA1BACE1RAB9A
SCHEMBL11811006 0.70 MEN1 (0.41) ALDH1A1MEN1KMT2APOLBHPGD
SCHEMBL26928523 0.67 ALDH1A1 (0.44) ALDH1A1POLBRAB9AMAPTSMN1; SMN2
SCHEMBL29638539 0.67 IDO1 (0.39) MEN1KMT2ARAB9AGAAMAPT
SCHEMBL24338058 0.66 PDE3B (0.42) ALDH1A1HPGDPDE10ATRPA1RAB9A
SCHEMBL30051661 0.66 TRPA1 (0.38) ALDH1A1MEN1KMT2APDE10ATRPA1
SCHEMBL30174517 0.66 TRPA1 (0.38) ALDH1A1MEN1KMT2AHPGDPDE10A
SCHEMBL24338060 0.66 TRPA1 (0.38) ALDH1A1MEN1KMT2AHPGDPDE10A
SCHEMBL31207063 0.66 PDE3B (0.42) ALDH1A1HPGDPDE10ATRPA1RAB9A
SCHEMBL28394815 0.66 TRPA1 (0.38) ALDH1A1MEN1KMT2ATRPA1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260042760-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH CALCITONIN RECEPTOR AND/OR AMYLIN RECEPTOR ACTIVITY ACONCAGUA BIO INC (US) 2026-02-12 — — US disclosed
US-12486269-B2 Compounds and compositions for treating conditions associated with calcitonin receptor and/or amylin receptor activity ACONCAGUA BIO, INC. (US) 2025-12-02 — — US disclosed
US-20250257067-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH CALCITONIN RECEPTOR AND/OR AMYLIN RECEPTOR ACTIVITY ACONCAGUA BIO, INC. 2025-08-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12486269-B2 Compounds and compositions for treating conditions associated with calcitonin receptor and/or amylin receptor activity IAPP, GIPR, SCTR ALDH1A1 4002/4885MEN1 812/4885KMT2A 4800/4885
US-20260042760-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH CALCITONIN RECEPTOR AND/OR AMYLIN RECEPTOR ACTIVITY NPY1R, CALCRL, SCTR ALDH1A1 3320/4885MEN1 750/4885KMT2A 4755/4885
US-20250257067-A1 COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH CALCITONIN RECEPTOR AND/OR AMYLIN RECEPTOR ACTIVITY IAPP, GIPR, SCTR ALDH1A1 4002/4885MEN1 812/4885KMT2A 4800/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback